November 29, 2015 |
The University of Pennsylvania's Lancaster General Hospital has begun work on a $60 million expansion in downtown Lancaster that will allow the 533-bed facility to convert to all private rooms. Penn completed its acquisition of Lancaster General on August 1. No money changed hands, but the deal added $1 billion in net assets to Penn's balance sheet. Combined, the two systems had $76.76 million in operating profits on $1.29 billion in total revenue in the quarter ended Sept. 30. firstname.lastname@example.org 215-854-4651 @InqBrubaker
May 5, 2014 |
Quaker Chemical Corp. doesn't swing for the fences. No, the Conshohocken-based specialty chemical-maker likes to play small ball - watching costs, stressing customer service, making key acquisitions - to keep its balance sheet with a positive tilt. "Our goal is to score runs by hitting many singles," Quaker's chief executive officer, Michael Barry, told stock analysts last week. By Wall Street's measure, Quaker has been hitting the ball pretty well. Since sinking below $5 a share during the Great Recession, its stock has risen fairly steadily.
March 31, 2014 |
Some people, and some companies, look for stability when faced with tumultuous times. Exton-based WPCS International is trying a slightly different tack in meeting its challenges. WPCS, which says it employs about 250 in designing and building communications infrastructure, is diving into bitcoin. Or rather, the technology of trading bitcoin. In existence - virtually - for only a few years, bitcoin is digital money. No central government authority backs bitcoin, as the U.S. government does with the dollar and as other governments do with their currencies.
January 21, 2014 |
What, you might ask, could possibly be interesting about being an auditor? Isn't it mind-numbing, dealing with dense financial documents coupled with excruciatingly arcane regulations? Not for Robert J. McNeill, 48, the newly elected chairman of the Economy League of Greater Philadelphia and the managing partner of Deloitte's 1,500-employee Philadelphia office. To him, the audit practice provides an opportunity to learn about many different business sectors - without actually having to work in them.
January 17, 2014 |
THE Jack Ryan franchise falls to Chris Pine in "Shadow Recruit," a giant do-over that rescues Ryan from middle age and plops him into a new generation. We meet Pine's Ryan pre-CIA: a prologue has him as an undergrad studying in the U.K., witnessing 9/11 from afar, enlisting as a Marine. He is finally recruited to the agency (by Kevin Costner), which plants him undercover on Wall Street to look for sources of terrorist funding. This he does, uncovering a massive scheme to undermine the value of the U.S. dollar (insert Ben Bernanke joke here)
January 8, 2014 |
Philadelphia Orphans' Court Judge John W. Herron was in no hurry Monday to rubber-stamp the Archdiocese of Philadelphia's plan to lease its cemeteries to a for-profit company for $89 million. The proposal is the biggest step yet taken by Archbishop Charles J. Chaput to try to fill deep financial holes in the balance sheet of the five-county archdiocese. Herron questioned whether he had the authority to rule, given that the cemeteries in the agreement with StoneMor Partners L.P., of Levittown, are spread over five counties.
December 16, 2013 |
It was in the depths of the real estate downturn, June 2010, that Robert I. Toll, cofounder of the luxury home builder Toll Bros. Inc., stepped down as chief executive officer and handed the reins to Douglas C. Yearley Jr. The move had been in the works for a while, but as Yearley recalled in a recent interview at corporate headquarters in Horsham, "Bob wanted to wait a bit until the market showed signs of improvement. " "He didn't want to dump a huge mess into my lap," said Yearley, 53, who joined Toll Bros.
July 4, 2013 |
The Archdiocese of Philadelphia on Wednesday reported a staggering $39.2 million loss for the year ended June 30, 2012, while disclosing unprecedented details about longterm financial deficits totaling $350 million. Even after stripping away millions in unusual expenses, including $11.9 million for legal and professional services related to the priest sex-abuse scandal and other issues, the archdiocese said its cash expenses 2012 still exceeded revenue by $17.4 million. "It's not so simple to say our problems are related to the sexual-abuse crisis," Timothy O'Shaughnessy, chief financial officer for the archdiocese, said.
March 14, 2013 |
More than a year after receiving regulatory approval for its first drug, Discovery Laboratories Inc. still has not launched Surfaxin, a treatment to prevent a respiratory illness that affects premature infants. The Warrington biotechnology firm now says it expects to begin selling Surfaxin to hospitals during the second quarter after delaying the launch last October. The company said the delay was related to one of the analytical chemistry methods used to assess how the synthetic drug conforms to its product specifications.
February 7, 2013
Q: Where can I see historical price-to-earnings (P/E) ratios? - D.L., Columbus, Ind. A: It's good to seek out such numbers, because when you compare them with a company's recent P/E, you get a sense of how overvalued or undervalued it might be. The website ycharts.com has several years' worth of P/E numbers. At morningstar.com, enter the ticker symbol to get to a company's page, then click on the "Valuation" tab. You'll get the current P/E, the average P/E for the company's industry, the S&P 500's current P/E and the company's five-year average P/E. There's even a "forward" P/E based on expected earnings over the coming year.